Neurooncol Adv

Rare germline variants contribute to glioma predisposition: Whole-genome analysis of a regional cohort of glioma patients.

Rosenbaum A, Wibom C, Hammermeister Suger A, ..., Dahlin AM, Melin B

Neurooncol Adv 8 (1) vdag038 [2026-02-12; online 2026-02-12]

NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression.

Wicher G, Roy A, Vaccaro A, ..., Dimberg A, Forsberg-Nilsson K

Neurooncol Adv 7 (1) vdaf010 [2025-01-27; online 2025-01-27]

NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Genomic tumor evolution dictates human medulloblastoma progression.

Ruchiy Y, Tsea I, Preka E, ..., Johnsen JI, Baryawno N

Neurooncol Adv 6 (1) vdae172 [2024-10-05; online 2024-10-05]

Bioinformatics Support for Computational Resources [Service]

The potential of liquid biopsy for detection of the KIAA1549-BRAF fusion in circulating tumor DNA from children with pilocytic astrocytoma.

Krynina O, de Ståhl TD, Jylhä C, ..., Tham E, Sandvik U

Neurooncol Adv 6 (1) vdae008 [2024-01-24; online 2024-01-24]

Bioinformatics Support for Computational Resources [Service]

Glioblastoma cytotoxicity conferred through dual disruption of endolysosomal homeostasis by Vacquinol-1.

Kwak D, Hammarström LGJ, Haraldsson M, Ernfors P

Neurooncol Adv 3 (1) vdab152 [2021-10-15; online 2021-10-15]

Chemical Biology Consortium Sweden [Collaborative]